HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Alexander Quaas Selected Research

Cell Adhesion Molecules

12/2008Universal expression of cell adhesion molecule NCAM in neuroblastoma in contrast to L1: implications for different roles in tumor biology of neuroblastoma?
12/2007L1 is associated with favorable outcome in neuroblastomas in contrast to adult tumors.
11/2007L1 is associated with micrometastatic spread and poor outcome in colorectal cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Alexander Quaas Research Topics

Disease

77Neoplasms (Cancer)
11/2022 - 03/2006
34Adenocarcinoma
09/2022 - 01/2007
13Carcinoma (Carcinomatosis)
11/2022 - 01/2017
13Neoplasm Metastasis (Metastasis)
08/2022 - 03/2006
7Squamous Cell Carcinoma of Head and Neck
11/2021 - 01/2017
6Inflammation (Inflammations)
12/2020 - 03/2013
6Breast Neoplasms (Breast Cancer)
05/2017 - 01/2007
5Esophageal Neoplasms (Esophageal Cancer)
04/2022 - 01/2007
5Squamous Cell Carcinoma (Epidermoid Carcinoma)
02/2021 - 10/2013
5Prostatic Neoplasms (Prostate Cancer)
01/2016 - 03/2014
4Stomach Neoplasms (Stomach Cancer)
01/2022 - 05/2017
4Hepatocellular Carcinoma (Hepatoma)
04/2021 - 09/2009
4Lymphatic Metastasis
10/2020 - 04/2018
4Neuroblastoma
04/2010 - 12/2007
3Pancreatic Neoplasms (Pancreatic Cancer)
09/2022 - 11/2020
3Turcot syndrome
10/2021 - 02/2019
3Melanoma (Melanoma, Malignant)
01/2021 - 01/2015
3Sarcoma (Soft Tissue Sarcoma)
11/2020 - 01/2019
3Disease Progression
10/2020 - 12/2008
3Colorectal Neoplasms (Colorectal Cancer)
01/2019 - 11/2007
3Cholangitis
01/2017 - 10/2013
2Adenoid Cystic Carcinoma (Cylindroma)
11/2022 - 02/2016
2Margins of Excision
08/2022 - 03/2014
2Lymphoma (Lymphomas)
06/2022 - 10/2016
2Infections
04/2022 - 11/2014
2Hypoxia (Hypoxemia)
01/2022 - 01/2019
2Cholangiocarcinoma
01/2022 - 05/2021
2Triple Negative Breast Neoplasms
12/2021 - 07/2012
2Microsatellite Instability
10/2021 - 01/2021
2Tertiary Lymphoid Structures
01/2021 - 01/2019
2Lung Neoplasms (Lung Cancer)
01/2021 - 10/2012
2Sclerosing Cholangitis
01/2017 - 01/2015
2Liver Diseases (Liver Disease)
01/2017 - 03/2015
2Fibrosis (Cirrhosis)
01/2015 - 09/2013
2Liver Failure
11/2014 - 10/2013
2Autoimmune Hepatitis
03/2013 - 07/2012
1Seminoma
04/2022
1COVID-19
04/2022
1Residual Neoplasm
04/2022

Drug/Important Bio-Agent (IBA)

20Proteins (Proteins, Gene)FDA Link
09/2022 - 11/2007
11Biomarkers (Surrogate Marker)IBA
09/2022 - 04/2010
10RNA (Ribonucleic Acid)IBA
06/2022 - 01/2008
8Monoclonal AntibodiesIBA
01/2020 - 11/2007
7ParaffinIBA
04/2022 - 02/2012
7Immune Checkpoint InhibitorsIBA
06/2021 - 01/2019
7Messenger RNA (mRNA)IBA
01/2021 - 12/2008
6Formaldehyde (Formol)FDA Link
04/2022 - 10/2013
6Biological ProductsIBA
10/2020 - 01/2008
5AntigensIBA
04/2021 - 07/2015
4CytokinesIBA
06/2019 - 12/2008
4TubulinIBA
12/2017 - 03/2014
3Eosine Yellowish-(YS) (Eosin)IBA
01/2022 - 03/2021
3Interleukin-17 (Interleukin 17)IBA
10/2021 - 03/2015
3InterferonsIBA
04/2021 - 11/2020
3AntibodiesIBA
01/2021 - 01/2019
3Trastuzumab (Herceptin)FDA Link
01/2020 - 01/2007
3Pharmaceutical PreparationsIBA
05/2017 - 03/2013
3Prostate-Specific Antigen (Semenogelase)IBA
04/2015 - 03/2014
3Immunoglobulin G (IgG)IBA
01/2015 - 03/2013
3Neural Cell Adhesion Molecule L1 (L1 Cell Adhesion Molecule)IBA
04/2012 - 03/2006
3Cell Adhesion MoleculesIBA
12/2008 - 11/2007
2Hematoxylin (Haematoxylon)IBA
01/2022 - 03/2021
2DNA (Deoxyribonucleic Acid)IBA
11/2021 - 01/2021
2LigandsIBA
06/2021 - 01/2017
2Carrier Proteins (Binding Protein)IBA
04/2021 - 09/2018
2Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
02/2021 - 10/2012
2Chemokine ReceptorsIBA
02/2021 - 04/2020
2Immune Checkpoint ProteinsIBA
12/2020 - 01/2017
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2020 - 01/2019
2Rituximab (Mabthera)FDA Link
01/2020 - 01/2019
2DesminIBA
12/2018 - 03/2006
2VimentinIBA
01/2018 - 03/2006
2Progesterone Receptors (Progesterone Receptor)IBA
08/2016 - 03/2016
2Transaminases (Aminotransferases)IBA
01/2015 - 03/2013
2SteroidsIBA
11/2014 - 10/2013
2Peroxidase (Myeloperoxidase)IBA
12/2008 - 12/2007
1PlatinumIBA
11/2022
1Axitinib (AG 013736)IBA
11/2022
1EnzymesIBA
09/2022
1Fructose-BisphosphataseIBA
09/2022
1(+)-JQ1 compoundIBA
09/2022
1ProcollagenIBA
06/2022
1Androgen Receptors (Androgen Receptor)IBA
04/2022
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
01/2022
1Surface Antigens (Surface Antigen)IBA
12/2021
1sacituzumab govitecanIBA
12/2021
1Immunoconjugates (Immunoconjugate)IBA
12/2021
1Irinotecan (Camptosar)FDA LinkGeneric
11/2021
1Fluorouracil (Carac)FDA LinkGeneric
11/2021
1Leucovorin (Folinic Acid)FDA Link
11/2021
1Oxaliplatin (Eloxatin)FDA LinkGeneric
11/2021
1Interleukin-6 (Interleukin 6)IBA
10/2021

Therapy/Procedure

34Therapeutics
11/2022 - 06/2007
13Neoadjuvant Therapy
08/2022 - 12/2017
8Immunotherapy
01/2022 - 01/2017
7Drug Therapy (Chemotherapy)
11/2022 - 01/2017
2Esophagectomy
04/2022 - 08/2020
2Lasers (Laser)
10/2013 - 02/2013
1Neck Dissection (Radical Neck Dissection)
05/2022
1Combined Modality Therapy
04/2022